<p>(A) 1×10<sup>6</sup> ES cells or <i>in vitro</i> differentiated cells were injected subcutaneously at day 0 into syngeneic 129Sv mice (for the numbers of animals see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0002622#pone-0002622-t002" target="_blank">Table 2</a>) which were treated daily with CsA (10 mg/kg body weight). The tumor size was recorded every second day until day 100 using linear calipers. The growth of tumors in individual mice is shown. Tumor growth in female hosts is indicated by red lines and male hosts by blue lines. (B) 1×10<sup>6</sup> cells differentiated <i>in vitro</i> for 14 days were injected subcutaneously into LOU/c rats (n = 18) which were treated daily with CsA (10 mg/kg body weight)...
<p>(A) Growth of tumor volume in SE and EE mice, EE decreased tumor growth rate (n = 10–12 per group...
<p>After 11 days of tumor inoculation, tumors were touchable. Then mice were randomly regrouped (n =...
<p>(A) Summary of tumor initiation. Tumor-initiating abilities were evaluated at day 33 after inject...
<p>(A) 1×10<sup>6</sup> ES cells (MPI-II) or <i>in vitro</i> differentiated cells (day 14 of differe...
<p>ES cells and cells differentiated <i>in vitro</i> for 14 days were injected subcutaneously into t...
<p>The indicated number of ES cells and cells differentiated <i>in vitro</i> for 14 days were inject...
<p>A, Tumor incidence from 3 experiments. Equal numbers of sex matched SCID mice were injected s.c. ...
<p>Shows the progressive formation of ascites/tumors when i.p. injected with ID8 cells. ID8 injected...
<p>BOWES PCMV6 and CXCR3 cells were injected interdermally into NSG mice (5 x 10<sup>5</sup> cells p...
<p>(<b>A</b>)Increasing numbers of CD271<sup>+</sup> (left) cells were injected subcutaneously in Ba...
a<p>Each experiment was conducted with tumor tissue derived from a different ovarian cancer patient....
<p>(A) Tumors growth was measured from day 20–32 (post-cell injection) and treated every other day *...
<p>(a). Mice (3–4 months old) were subcutaneously injected with 0.25×10<sup>6</sup> B16 melanoma cel...
<p>(<i>a</i>) Primary SC induce tumors in mice. (<i>b</i>) Tumor weight of the generated tumor xenog...
<p>A) Tumor volumes of xenografts generated by injection of spheres or adherent undifferentiated LMS...
<p>(A) Growth of tumor volume in SE and EE mice, EE decreased tumor growth rate (n = 10–12 per group...
<p>After 11 days of tumor inoculation, tumors were touchable. Then mice were randomly regrouped (n =...
<p>(A) Summary of tumor initiation. Tumor-initiating abilities were evaluated at day 33 after inject...
<p>(A) 1×10<sup>6</sup> ES cells (MPI-II) or <i>in vitro</i> differentiated cells (day 14 of differe...
<p>ES cells and cells differentiated <i>in vitro</i> for 14 days were injected subcutaneously into t...
<p>The indicated number of ES cells and cells differentiated <i>in vitro</i> for 14 days were inject...
<p>A, Tumor incidence from 3 experiments. Equal numbers of sex matched SCID mice were injected s.c. ...
<p>Shows the progressive formation of ascites/tumors when i.p. injected with ID8 cells. ID8 injected...
<p>BOWES PCMV6 and CXCR3 cells were injected interdermally into NSG mice (5 x 10<sup>5</sup> cells p...
<p>(<b>A</b>)Increasing numbers of CD271<sup>+</sup> (left) cells were injected subcutaneously in Ba...
a<p>Each experiment was conducted with tumor tissue derived from a different ovarian cancer patient....
<p>(A) Tumors growth was measured from day 20–32 (post-cell injection) and treated every other day *...
<p>(a). Mice (3–4 months old) were subcutaneously injected with 0.25×10<sup>6</sup> B16 melanoma cel...
<p>(<i>a</i>) Primary SC induce tumors in mice. (<i>b</i>) Tumor weight of the generated tumor xenog...
<p>A) Tumor volumes of xenografts generated by injection of spheres or adherent undifferentiated LMS...
<p>(A) Growth of tumor volume in SE and EE mice, EE decreased tumor growth rate (n = 10–12 per group...
<p>After 11 days of tumor inoculation, tumors were touchable. Then mice were randomly regrouped (n =...
<p>(A) Summary of tumor initiation. Tumor-initiating abilities were evaluated at day 33 after inject...